Jim Simons acquired 272 Thousand Apellis Pharmaceuticals shares worth $4.7 Million. That's 0.01% of their equity portfolio (1338th largest holding). The first Apellis Pharmaceuticals trade was made in Q1 2019. Since then Jim Simons bought shares six more times and sold shares on eight occasions. The investor's estimated purchase price is $10.1 Million, resulting in a loss of 53%.